Inventor · disambiguated record
Joachim Struck
Also filed as: STRUCK JOACHIM
66 granted patents·34 pending applications·578 citations·filing 1993–2021
99Inventor score
Top patents by PatentIndex Score
100 records- 0195US6756483B1Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infectionsBRAHMS AG·Filed 1999·Granted Jun 29, 2004·92 cites·1 claims
- 0294US9753039B2Prognosis of adverse events in patients with suspected chronic heart failureBRAHMS GMBH·Filed 2016·Granted Sep 5, 2017·6 cites·20 claims
- 0394US8354506B2Antibodies for the selective determination of procalcitonin 1-116BRAHMS GMBH·Filed 2008·Granted Jan 15, 2013·21 cites·4 claims
- 0494US7807397B2Diagnostic method for disorders using copeptinBRAHMS AG·Filed 2005·Granted Oct 5, 2010·21 cites·2 claims
- 0593US9541549B2Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determinationBRAHMS GMBH·Filed 2014·Granted Jan 10, 2017·9 cites·5 claims
- 0693US7723492B2Method for the detection of sepsis using procalcitonin-3-116BRAHMS AG·Filed 2008·Granted May 25, 2010·17 cites·9 claims
- 0792US8450463B2Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a methodBERGMANN ANDREAS·Filed 2012·Granted May 28, 2013·9 cites·14 claims
- 0892US7972799B2Method for determining sepsis using pro-ADMBRAHMS GMBH·Filed 2009·Granted Jul 5, 2011·14 cites·10 claims
- 0990US11241395B2Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious diseaseBRAHMS GMBH·Filed 2019·Granted Feb 8, 2022·2 cites·10 claims
- 1090US8183004B2Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infectionsBERGMANN ANDREAS·Filed 2006·Granted May 22, 2012·17 cites·4 claims
- 1189US9229013B2Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunctionBERGMANN ANDREAS·Filed 2010·Granted Jan 5, 2016·10 cites·17 claims
- 1289US8465941B2Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failureBERGMANN ANDREAS·Filed 2007·Granted Jun 18, 2013·14 cites·18 claims
- 1389US7157081B2Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsisBRAHMS AG·Filed 2002·Granted Jan 2, 2007·35 cites·8 claims
- 1488US8691512B2Method for the detection of sepsis by determining peptide prohormone levelsBERGMANN ANDREAS·Filed 2010·Granted Apr 8, 2014·8 cites·25 claims
- 1588US8252544B2Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patientsBERGMANN ANDREAS·Filed 2008·Granted Aug 28, 2012·13 cites·16 claims
- 1688US7132246B2Use of soluble cytokeratin-1-fragments in diagnostics and therapyBRAHMS AG·Filed 2002·Granted Nov 7, 2006·35 cites·7 claims
- 1787US8906857B2Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonistsBERGMANN ANDREAS·Filed 2009·Granted Dec 9, 2014·7 cites·7 claims
- 1887US8436135B2Diagnosis and risk stratification by determining the marker CT-proADMBERGMANN ANDREAS·Filed 2007·Granted May 7, 2013·5 cites·12 claims
- 1987US7498139B2Method for determining sepsis using pro-ANFBRAHMS AG·Filed 2004·Granted Mar 3, 2009·17 cites·4 claims
- 2086US8124366B2Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a methodBERGMANN ANDREAS·Filed 2005·Granted Feb 28, 2012·9 cites·15 claims
- 2186US7153662B2Inflammation-specific peptides and the uses thereofBRAHMS AG·Filed 2002·Granted Dec 26, 2006·26 cites·2 claims
- 2285US9261516B2Diagnosis and risk stratification using NT-proET-1BERGMANN ANDREAS·Filed 2008·Granted Feb 16, 2016·8 cites·18 claims
- 2385US8524463B2Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNPBERGMANN ANDREAS·Filed 2007·Granted Sep 3, 2013·10 cites·20 claims
- 2484US9513301B2Method for risk stratification in stable coronary artery diseaseBRAHMS GMBH·Filed 2015·Granted Dec 6, 2016·2 cites·2 claims
- 2584US9012151B2Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullinNG LEONG LOKE·Filed 2007·Granted Apr 21, 2015·12 cites·18 claims
- 2684US7998686B2Method for determining sepsis using pro-BNPBRAHMS GMBH·Filed 2008·Granted Aug 16, 2011·4 cites·11 claims
- 2783US8889366B2Marker for graft failure and mortalitySTRUCK JOACHIM·Filed 2009·Granted Nov 18, 2014·16 cites·22 claims
- 2879US10048280B2Immunoassay for the detection of procalcitoninBRAHMS GMBH·Filed 2017·Granted Aug 14, 2018·1 cites·9 claims
- 2979US8426180B2Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseasesBERGMANN ANDREAS·Filed 2011·Granted Apr 23, 2013·3 cites·3 claims
- 3079US7413850B2Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsisBRAHMS AG·Filed 2003·Granted Aug 19, 2008·10 cites·12 claims
- 3178US8691595B2Method for detecting analytesBERGMANN ANDREAS·Filed 2008·Granted Apr 8, 2014·5 cites·11 claims
- 3278US8501485B2Risk stratification for acute coronary syndrome by determining copeptinBERGMANN ANDREAS·Filed 2007·Granted Aug 6, 2013·4 cites·13 claims
- 3377US8647830B2Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac diseaseBERGMANN ANDREAS·Filed 2008·Granted Feb 11, 2014·5 cites·19 claims
- 3476US8853355B2Diagnosis and risk stratification by determining the marker CT-proADMBRAHMS GMBH·Filed 2013·Granted Oct 7, 2014·1 cites·14 claims
- 3575US9116153B2Arginine vasopressin pro-hormone as predictive biomarker for diabetesSTRUCK JOACHIM·Filed 2009·Granted Aug 25, 2015·3 cites·12 claims
- 3673US8735079B2Method for risk stratification in stable coronary artery diseaseBERGMANN ANDREAS·Filed 2008·Granted May 27, 2014·3 cites·2 claims
- 3773US7977072B2Sandwich immunoassay for identifying partial proANP peptidesBRAHMS GMBH·Filed 2003·Granted Jul 12, 2011·10 cites·7 claims
- 3872US9664689B2Method for the selective detection and measurement of procalcitonin 1-116 and amino-terminal peptides of procalcitonin comprising amino acids 1 and 2 of procalcitonin 1-116BRAHMS GMBH·Filed 2013·Granted May 30, 2017·1 cites·7 claims
- 3972US9488659B2Prognosis of adverse events in patients with suspected chronic heart failureBRAHMS GMBH·Filed 2013·Granted Nov 8, 2016·1 cites·17 claims
- 4072US8252548B2In vitro method for the detection of early-stage liver damageBERGMANN ANDREAS·Filed 2007·Granted Aug 28, 2012·3 cites·7 claims
- 4171US10456364B2Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious diseaseSTRUCK JOACHIM·Filed 2011·Granted Oct 29, 2019·1 cites·34 claims
- 4271US7235368B2CHP for use as marker for sepsis-type inflammatory diseasesBRAHMS AG·Filed 2002·Granted Jun 26, 2007·5 cites·3 claims
- 4368US9726675B2Diagnosis and risk stratification by determining the marker CT-proADMBRAHMS GMBH·Filed 2014·Granted Aug 8, 2017·0 cites·19 claims
- 4468US8158368B2Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin IIBERGMANN ANDREAS·Filed 2007·Granted Apr 17, 2012·1 cites·3 claims
- 4568US6537760B1Receptor binding assay for detecting TSH-receptor auto-antibodiesBRAHMS AG·Filed 1997·Granted Mar 25, 2003·36 cites·19 claims
- 4667US2019041408A1Immunoassay for the detection of procalcitoninBRAHMS GMBH·Filed 2018·Application pending·0 cites
- 4765US7405049B2Method for diagnosing inflammatory diseases and infections by the determination of LASP-1 immunoreactivityBRAHMS AG·Filed 2003·Granted Jul 29, 2008·3 cites·9 claims
- 4865US2018052179A1Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitoninBRAHMS GMBH·Filed 2017·Application pending·0 cites
- 4965US2018143190A1Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determinationBRAHMS GMBH·Filed 2018·Application pending·0 cites
- 5064US10954298B2Method of obtaining a binder to prepro-vasopressin or fragments thereofBRAHMS GMBH·Filed 2018·Granted Mar 23, 2021·0 cites·2 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joachim Struck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →